Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL686 (CI-473, CN-35355, Contraflam, Dysman-250, Dysman-500, Gardan, INF-3355, J2.344B, M01AG01, Mefenamate, Mefenamic acid, Mefenaminic acid, Meflam 250, Meflam 500, Mendys, Mephenamic acid, Mephenaminic acid, NSC-94437, Opustan 250, Opustan 500, Ponstan, Ponstan fte, Ponstel) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
Acetylcholinesterase in Torpedo californica (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4780] [UniProtKB: P04058] | ||||||||
ChEMBL | Inhibition of Torpedo californica eel AChE using acetylthiocholine/DTNB as substrate assessed as ROS-induced enzyme inactivation preincubated for 10 mins followed by substrate addition measured every 30 secs for 20 mins in presence of horseradish peroxidase and H2O2 | B | 5.21 | pIC50 | 6120 | nM | IC50 | Medchemcomm (2011) 2: 406-412 |
Aldo-keto reductase family 1 member B10 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5983] [UniProtKB: O60218] | ||||||||
ChEMBL | Inhibition of wild-type N-terminal 6-His tagged AKR1B10 (unknown origin) expressed in Escherichia coli BL21(DE3) assessed as pyridine-3-aldehyde reduction by spectrophotometry | B | 5.8 | pIC50 | 1600 | nM | IC50 | J Med Chem (2015) 58: 2047-2067 [PMID:25375908] |
Aldo-keto reductase family 1 member C1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5905] [UniProtKB: Q04828] | ||||||||
ChEMBL | Inhibition of human recombinant AKR1C1 assessed as 1-acenaphthenol oxidation by spectrophotometry | B | 6.09 | pKi | 810 | nM | Ki | J Med Chem (2012) 55: 7417-7424 [PMID:22881866] |
ChEMBL | Inhibition of AKR1C1 (unknown origin) | B | 5.41 | pIC50 | 3910 | nM | IC50 | Eur J Med Chem (2013) 62: 738-744 [PMID:23454516] |
Aldo-keto reductase family 1 member C2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5847] [UniProtKB: P52895] | ||||||||
ChEMBL | Inhibition of human recombinant AKR1C2 assessed as 1-acenaphthenol oxidation by spectrophotometry | B | 6.66 | pKi | 220 | nM | Ki | J Med Chem (2012) 55: 7417-7424 [PMID:22881866] |
ChEMBL | Inhibition of AKR1C2 (unknown origin) | B | 5.16 | pIC50 | 6970 | nM | IC50 | Eur J Med Chem (2013) 62: 738-744 [PMID:23454516] |
AKR1C3/Aldo-keto-reductase family 1 member C3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4681] [GtoPdb: 1382] [UniProtKB: P42330] | ||||||||
ChEMBL | Inhibition of human recombinant AKR1C3 assessed as 1-acenaphthenol oxidation by spectrophotometry | B | 6.52 | pKi | 300 | nM | Ki | J Med Chem (2012) 55: 7417-7424 [PMID:22881866] |
ChEMBL | Inhibition of AKR1C3 (unknown origin) | B | 6.25 | pIC50 | 560 | nM | IC50 | Eur J Med Chem (2013) 62: 738-744 [PMID:23454516] |
Aldo-keto reductase family 1 member C4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4999] [UniProtKB: P17516] | ||||||||
ChEMBL | Inhibition of AKR1C4 (unknown origin) | B | 4 | pIC50 | >100000 | nM | IC50 | Eur J Med Chem (2013) 62: 738-744 [PMID:23454516] |
aldo-keto reductase family 1 member B/Aldose reductase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1900] [GtoPdb: 2768] [UniProtKB: P15121] | ||||||||
ChEMBL | Inhibition of human AR by fluorescence assay | B | 4.11 | pIC50 | 77000 | nM | IC50 | J Med Chem (2015) 58: 2047-2067 [PMID:25375908] |
COX-1 /Cyclooxygenase-1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL221] [GtoPdb: 1375] [UniProtKB: P23219] | ||||||||
GtoPdb | - | - | 4.6 | pIC50 | 25000 | nM | IC50 | Eur J Med Chem (2013) 62: 738-44 [PMID:23454516] |
ChEMBL | Inhibition of COX1 (unknown origin) | B | 4.6 | pIC50 | 25000 | nM | IC50 | Eur J Med Chem (2013) 62: 738-744 [PMID:23454516] |
ChEMBL | DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid) | B | 6.94 | pIC50 | 116 | nM | IC50 | DrugMatrix in vitro pharmacology data |
COX-2 /Cyclooxygenase-2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL230] [GtoPdb: 1376] [UniProtKB: P35354] | ||||||||
ChEMBL | Inhibition of COX2 (unknown origin) | B | 5.54 | pIC50 | 2900 | nM | IC50 | Eur J Med Chem (2013) 62: 738-744 [PMID:23454516] |
GtoPdb | - | - | 5.54 | pIC50 | 2900 | nM | IC50 | Eur J Med Chem (2013) 62: 738-44 [PMID:23454516] |
ChEMBL | DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid) | B | 6.22 | pIC50 | 602 | nM | IC50 | DrugMatrix in vitro pharmacology data |
dihydrofolate reductase/Dihydrofolate reductase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL202] [GtoPdb: 2603] [UniProtKB: P00374] | ||||||||
ChEMBL | Inhibition of human DHFR in presence of DHF and NADPH by UV-vis spectrometry by Lineweaver-Burk plot analysis | B | 4.14 | pKi | 72000 | nM | Ki | J Med Chem (2020) 63: 8314-8324 [PMID:32658475] |
myeloperoxidase/Myeloperoxidase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2439] [GtoPdb: 2789] [UniProtKB: P05164] | ||||||||
ChEMBL | Inhibition of recombinant MPO (unknown origin) assessed as reduction in LDL oxidation in presence of H2O2 and HCl after 5 mins by ELISA | B | 5.66 | pIC50 | 2210 | nM | IC50 | J Med Chem (2017) 60: 6563-6586 [PMID:28671460] |
ChEMBL | Inhibition of recombinant MPO (unknown origin) assessed as reduction in taurine chloramine production preincubated with enzyme and taurine followed by H2O2 addition measured after 5 mins | B | 6.01 | pIC50 | 980 | nM | IC50 | J Med Chem (2017) 60: 6563-6586 [PMID:28671460] |
NLRP3/NACHT, LRR and PYD domains-containing protein 3 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3779755] [GtoPdb: 1770] [UniProtKB: Q8R4B8] | ||||||||
ChEMBL | Inhibition of NLRP3 inflammasome activation in LPS-primed C57BL/6 mouse bone marrow derived macrophages preincubated for 15 mins followed by addition of ATP and measured after 1 hr by ELISA | B | 4.6 | pIC50 | 25000 | nM | IC50 | Eur J Med Chem (2020) 185: 111822-111822 [PMID:31699536] |
Nicotinate phosphoribosyltransferase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4523354] [UniProtKB: Q6XQN6] | ||||||||
ChEMBL | Inhibition of NAPRT (unknown origin) | B | 10.3 | pKi | 0.05 | nM | Ki | WO-2017162840-A1. Sensitization of cancer cells to nampt inhibitors by nicotinic acid phosphoribosyltransferase neutralization (2017) |
TRPA1/Transient receptor potential cation channel subfamily A member 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6007] [GtoPdb: 485] [UniProtKB: O75762] | ||||||||
ChEMBL | Agonist activity at human TRPA1 in WI38 cells assessed as increase in calcium influx by Fluo-4-AM dye based fluorescence assay | B | 4.21 | pEC50 | 61000 | nM | EC50 | Eur J Med Chem (2019) 170: 141-156 [PMID:30878828] |
ChEMBL | Agonist activity at human TRPA1 expressed in HEK293 cells assessed as increase in calcium influx by Fluo-4-AM dye based fluorescence assay | B | 4.78 | pEC50 | 16595.87 | nM | EC50 | Eur J Med Chem (2019) 170: 141-156 [PMID:30878828] |
ChEMBL | Agonist activity at human TRPA1 expressed in HEK293 cells assessed as increase in calcium influx by Fluo-4-AM dye based fluorescence assay | B | 4.8 | pEC50 | 16000 | nM | EC50 | Eur J Med Chem (2019) 170: 141-156 [PMID:30878828] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]